Literature DB >> 19169132

Inner ear anomalies and conductive hearing loss in children with Apert syndrome: an overlooked otologic aspect.

Guangwei Zhou1, Lynn Thomas Schwartz, Quinton Gopen.   

Abstract

OBJECTIVE: To identify the occurrence of inner ear structural anomalies and conductive hearing loss (CHL) in children with Apert syndrome. STUDY
DESIGN: Retrospective review.
SETTING: Pediatric tertiary referral center. PATIENTS: Twenty pediatric patients with Apert syndrome were found; all patients (38/40 ears) had inner ear anomalies. INTERVENTION(S): Computerized tomography of the head/temporal bone, pure-tone (including air and bone conduction) audiometry, and tympanometry. MAIN OUTCOME MEASURE(S): Imaging demonstrating inner ear anomalies, including malformations of the cochlea, dilated vestibule, and/or semicircular canal; audiologic findings of air-bone gap(s).
RESULTS: Hearing loss was found in 90% of the patients with Apert syndrome, and 80% of them had CHL. Air-bone gaps were found at all frequencies, with larger gaps at low frequencies. Fifty percent (20/40) of the ears had better than 0 dB hearing level bone conduction thresholds at 250 and/or 500 Hz. Normal middle ear pressure and mobility were found in all ears with intact eardrum. Inner ear anomalies were found in all patients, and 90% of them had bilateral involvement. Most frequently observed inner ear anomalies were dilated vestibule, malformed lateral semicircular canal, and cochlear dysplasia.
CONCLUSION: Children with Apert syndrome may present with significant CHL that cannot be explained by minor middle ear pathologies alone. This conductive loss may be, at least partially, attributed to the inner ear anomalies; however, these structural anomalies are usually not recognized in these patients. Failure to close air-bone gap after surgical intervention may raise the suspicion of inner ear anomalies, and computed tomographic scan of the temporal bone can provide definitive proof.

Entities:  

Mesh:

Year:  2009        PMID: 19169132     DOI: 10.1097/MAO.Ob013e318191a352

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.

Authors:  Irene M J Mathijssen
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

Review 2.  Hearing loss in syndromic craniosynostoses: introduction and consideration of mechanisms.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Maximilian Muenke
Journal:  Am J Audiol       Date:  2014-06       Impact factor: 1.493

Review 3.  Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Maximilian Muenke
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

4.  Phenotype profile of a genetic mouse model for Muenke syndrome.

Authors:  Hyun-Duck Nah; Eiki Koyama; Nneamaka B Agochukwu; Scott P Bartlett; Maximilian Muenke
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

5.  A requirement for Fgfr2 in middle ear development.

Authors:  Diana Rigueur; Ryan R Roberts; Lauren Bobzin; Amy E Merrill
Journal:  Genesis       Date:  2018-10-04       Impact factor: 2.487

6.  Analysis of the Fgfr2C342Y mouse model shows condensation defects due to misregulation of Sox9 expression in prechondrocytic mesenchyme.

Authors:  Emma Peskett; Samin Kumar; William Baird; Janhvi Jaiswal; Ming Li; Priyanca Patel; Jonathan A Britto; Erwin Pauws
Journal:  Biol Open       Date:  2017-02-15       Impact factor: 2.422

7.  Clinical study and some molecular features of Mexican patients with syndromic craniosynostosis.

Authors:  Aurora Ibarra-Arce; Manuel Almaraz-Salinas; Víctor Martínez-Rosas; Gabriela Ortiz de Zárate-Alarcón; Laura Flores-Peña; Mirza Romero-Valdovinos; Angélica Olivo-Díaz
Journal:  Mol Genet Genomic Med       Date:  2020-06-08       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.